And it enhances insulin secretion in a glucose-dependent manner, meaning it helps regulate blood sugar without causing dangerous hypoglycemia in most patients
Current demand for the mediation is outpacing production
These drawbacks are further exacerbated by the susceptibility of the essential 3-hydroxysulfate to hydrolysis by sulfatases
Side effects can still happen, they may not work for everyone, and medication works best alongside healthy nutrition, movement, and ongoing medical guidance
These decisions continue to have major implications on which corner of the life sciences tools and services space captures the most value: do the large bioprocessing platform players (e.g., Thermo Fisher, Cytiva, Sartorius) see an uplift, or do the specialized peptide synthesis equipment vendors and CDMOs benefit most (e.g., CEM Corporation, AAPPTec, Bachem, PolyPeptide)